The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement that provides best-practice guidance for the treatment of patent ductus arteriosus (PDA) using ...

“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...

Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.

(KPLC) - Forty-thousand babies a year are born with congenital heart disease, and about one in four of those infants has a life-threatening condition that affects how the heart is shaped, how it works ...

Patent ductus arteriosus (PDA) remains a prominent clinical challenge in the management of preterm infants. During fetal life, the ductus arteriosus diverts blood away from the underdeveloped lungs, ...

The persistence of the ductus arteriosus in preterm infants is a well‐documented contributor to morbidity, as the failure of this fetal vessel to close can result in significant haemodynamic ...